Citations (161)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Kamilla N. Alieva, Maria V. Golikova, Yury A. Portnoy, Svetlana A. Dovzhenko, Mikhail B. Kobrin, Stephen H. Zinner & Alexander A. Firsov. (2018) Concentration-dependent enrichment of resistant Enterococcus faecium exposed to linezolid in an in vitro dynamic model. Journal of Chemotherapy 30:6-8, pages 364-370.
Read now
Read now
Antonios Douros, Katja Grabowski & Ralf Stahlmann. (2015) Drug–drug interactions and safety of linezolid, tedizolid, and other oxazolidinones. Expert Opinion on Drug Metabolism & Toxicology 11:12, pages 1849-1859.
Read now
Read now
Lorenzo Zaffiri, Jared Gardner & Luis H. Toledo-Pereyra. (2013) History of Antibiotics: From Fluoroquinolones to Daptomycin (Part 2). Journal of Investigative Surgery 26:4, pages 167-179.
Read now
Read now
Yasuhiro Tsuji, Yoichi Hiraki, Kana Matsumoto, Akiko Mizoguchi, Shinichi Sadoh, Tsutomu Kobayashi, Seisaburo Sakamoto, Kunihiko Morita, Eiji Yukawa, Hidetoshi Kamimura & Yoshiharu Karube. (2012) Evaluation of the pharmacokinetics of linezolid in an obese Japanese patient. Scandinavian Journal of Infectious Diseases 44:8, pages 626-629.
Read now
Read now
Sally Ager & Kate Gould. (2012) Clinical update on linezolid in the treatment of Gram-positive bacterial infections. Infection and Drug Resistance 5, pages 87-102.
Read now
Read now
Yasuhiro Tsuji, Yoichi Hiraki, Kana Matsumoto, Akiko Mizoguchi, Shinichi Sadoh, Tsutomu Kobayashi, Yusuke Takemura, Seisaburo Sakamoto, Kunihiko Morita, Hidetoshi Kamimura & Yoshiharu Karube. (2011) Pharmacokinetics and protein binding of linezolid in cerebrospinal fluid and serum in a case of post-neurosurgical bacterial meningitis. Scandinavian Journal of Infectious Diseases 43:11-12, pages 982-985.
Read now
Read now
Cesar A Arias & Barbara E Murray. (2008) Emergence and management of drug-resistant enterococcal infections. Expert Review of Anti-infective Therapy 6:5, pages 637-655.
Read now
Read now
Joseph F John & Alexander M Harvin. (2007) History and evolution of antibiotic resistance in coagulase-negative staphylococci: Susceptibility profiles of new anti-staphylococcal agents. Therapeutics and Clinical Risk Management 3:6, pages 1143-1152.
Read now
Read now
Konstantinos Z Vardakas, Fotinie Ntziora & Matthew E Falagas. (2007) Linezolid: effectiveness and safety for approved and off-label indications. Expert Opinion on Pharmacotherapy 8:14, pages 2381-2400.
Read now
Read now
José-Luis Portero$suffix/text()$suffix/text() & Maria Rubio$suffix/text()$suffix/text(). (2007) New anti-tuberculosis therapies. Expert Opinion on Therapeutic Patents 17:6, pages 617-637.
Read now
Read now
Florian ME Wagenlehner, Wolfgang Weidner & Kurt G Naber. (2005) Emerging drugs for bacterial urinary tract infections. Expert Opinion on Emerging Drugs 10:2, pages 275-298.
Read now
Read now
Norbert Polacek & Alexander S. Mankin. (2005) The Ribosomal Peptidyl Transferase Center: Structure, Function, Evolution, Inhibition. Critical Reviews in Biochemistry and Molecular Biology 40:5, pages 285-311.
Read now
Read now
Cindy M. Nguyen, Lisa L. Larive & Denise H. Rhoney. (2003) Linezolid: Implications for neurosurgical infections. Neurological Research 25:1, pages 22-26.
Read now
Read now
Glenn W Kaatz & Michael J Rybak. (2001) Oxazolidinones: new players in the battle against multi-resistant Gram-positive bacteria. Emerging Drugs 6:1, pages 43-55.
Read now
Read now
Michael J Genin. (2000) Recent progress with oxazolidinone antibacterial agents. Expert Opinion on Therapeutic Patents 10:9, pages 1405-1414.
Read now
Read now
Articles from other publishers (146)
Magnus Bock, Johan G C Van Hasselt, Franziska Schwartz, Hengzhuang Wang, Niels Høiby, Kurt Fuursted, Nikolaj Ihlemann, Sabine Gill, Ulrik Christiansen, Niels Eske Bruun, Hanne Elming, Jonas A Povlsen, Lars Køber, Dan E Høfsten, Emil L Fosbøl, Mia M Pries-Heje, Jens Jørgen Christensen, Flemming S Rosenvinge, Christian Torp-Pedersen, Jannik Helweg-Larsen, Niels Tønder, Kasper Iversen, Henning Bundgaard & Claus Moser. (2023) Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditis. Journal of Antimicrobial Chemotherapy 78:12, pages 2840-2848.
Crossref
Crossref
Giulia Saneti Grandini, Nelson Henrique Morgon & Aguinaldo Robinson de Souza. (2023)
Theoretical study of the interaction between the antibiotic linezolid and the active site of the 50S ribosomal subunit of the bacterium
Haloarcula marismortui
. Chirality.
Crossref
Crossref
Karin Veerman, Jon Goosen, Karin Spijkers, Nynke Jager, Petra Heesterbeek & Denise Telgt. (2023) Prolonged use of linezolid in bone and joint infections: a retrospective analysis of adverse effects. Journal of Antimicrobial Chemotherapy 78:11, pages 2660-2666.
Crossref
Crossref
Pingxian Liu, Yunhan Jiang, Ling Jiao, Youfu Luo, Xiaodong Wang & Tao Yang. (2023) Strategies for the Discovery of Oxazolidinone Antibacterial Agents: Development and Future Perspectives. Journal of Medicinal Chemistry 66:20, pages 13860-13873.
Crossref
Crossref
Xuhua Xia. (2023) Horizontal Gene Transfer and Drug Resistance Involving Mycobacterium tuberculosis. Antibiotics 12:9, pages 1367.
Crossref
Crossref
Xin Yang, Lekai Xu, Yaqiong Zhu, Shaojun Zhang, Guanwei Jia & Jiang Du. (2023) Efficient fabrication of oxazolidinones for the carboxylative cyclization with carbon dioxide. Journal of CO2 Utilization 74, pages 102531.
Crossref
Crossref
Katsunori Suzuki, Mitsumasa Saito & Hideaki Hanaki. (2023) Increased copy number of 23S ribosomal RNA gene with point mutation in MRSA associated with linezolid resistance in a patient treated with long-term linezolid. Journal of Infection and Chemotherapy 29:5, pages 481-484.
Crossref
Crossref
Guanxuanzi Zhang, Na Zhang, Liuhan Dong, Nan Bai & Yun Cai. (2022) Development and Validation of an LC-MS/MS Method for the Quantitative Determination of Contezolid in Human Plasma and Cerebrospinal Fluid. Pharmaceuticals 16:1, pages 32.
Crossref
Crossref
Satoshi Fujii. (2022) Antimicrobial Stewardship Initiatives and Studies by the Hospital Pharmacist: Study of Linezolid-associated Thrombocytopenia抗菌薬適正使用に向けた病院薬剤師としての取り組みと研究─リネゾリド関連血小板減少症の研究─. YAKUGAKU ZASSHI 142:12, pages 1307-1312.
Crossref
Crossref
Lingxin Kong, Zixin Deng & Delin You. (2022) Chemistry and biosynthesis of bacterial polycyclic xanthone natural products. Natural Product Reports 39:11, pages 2057-2095.
Crossref
Crossref
Megumi Ikura, Kazuki Nakagita, Takaya Uno, Hiromi Takenaka, Sachi Matsuda, Miho Yoshii, Rikako Nagata, Ichiro Nakakura, Naoki Hayakawa, Tsutomu Nakamura, Kyoichi Wada & Osamu Seguchi. 2022. Heart Transplantation - New Insights in Therapeutic Strategies. Heart Transplantation - New Insights in Therapeutic Strategies.
Ayesha Murtaza, Muhammad Awais Qamar, Kaynat Saleem, Tomas Hardwick, Zia ul haq, Bahareh Shirinfar & Nisar Ahmed. (2022) Renewable Electricity Enables Green Routes to Fine Chemicals and Pharmaceuticals. The Chemical Record 22:5.
Crossref
Crossref
Ravleen Kaur, Pooja Rani, Atanas G. Atanasov, Qushmua Alzahrani, Reena Gupta, Bhupinder Kapoor, Monica Gulati & Pooja Chawla. (2022) Discovery and Development of Antibacterial Agents: Fortuitous and Designed. Mini-Reviews in Medicinal Chemistry 22:7, pages 984-1029.
Crossref
Crossref
Samer S. Daher, Miseon Lee, Xiao Jin, Christiana N. Teijaro, Pamela R. Barnett, Joel S. Freundlich & Rodrigo B. Andrade. (2022) Alternative approaches utilizing click chemistry to develop next-generation analogs of solithromycin. European Journal of Medicinal Chemistry 233, pages 114213.
Crossref
Crossref
Nicole C. Cardoso, Kelly Chibale & Vinayak Singh. (2022)
Implications of
Mycobacterium tuberculosis
Metabolic Adaptability on Drug Discovery and Development
. ACS Infectious Diseases 8:3, pages 414-421.
Crossref
Crossref
Chang Liu, Christina Abdel Shaheed, Lars Christian Braten, Mark J Hancock, Martin Underwood, Jeffrey G Jarvik, Julian Elliott, Christopher G Maher, Rachelle Buchbinder & Chung-Wei Christine Lin. (2021) Antibiotic treatment for low back pain or radicular pain, or both. Cochrane Database of Systematic Reviews 2021:9.
Crossref
Crossref
Siheng Wang, Chang Cai, Yingbo Shen, Chengtao Sun, Qingxin Shi, Ningjun Wu, Shufang Zheng, Jiao Qian, Rong Zhang & Hongwei Zhou. (2021) In vitro Activity of Contezolid Against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus, and Strains With Linezolid Resistance Genes From China. Frontiers in Microbiology 12.
Crossref
Crossref
Dong-Hyun Kim & Jung-Hyun Kim. (2021) Efficacy of Tigecycline and Linezolid Against Pan-Drug-Resistant Bacteria Isolated From Companion Dogs in South Korea. Frontiers in Veterinary Science 8.
Crossref
Crossref
Oriana Jovanovic, Carlos F. Amábile-Cuevas, Chii Shang, Chao Wang & King Wah Ngai. (2021) What Water Professionals Should Know about Antibiotics and Antibiotic Resistance: An Overview. ACS ES&T Water 1:6, pages 1334-1351.
Crossref
Crossref
Zemin He, Ping Yu, Yuzhen Zhao, Huimin Zhang, Yongming Zhang, Xiaoxi Kang, Haiquan Zhang & Seyed Mohsen Sadeghzadeh. (2020) PrVO4/SnD NPs as a Nanocatalyst for Carbon Dioxide Fixation to Synthesis Benzimidazoles and 2-Oxazolidinones. Catalysis Letters 151:6, pages 1623-1632.
Crossref
Crossref
Wen Wang, Kate M. Voss, Jinqian Liu & Mikhail F. Gordeev. (2021) Nonclinical Evaluation of Antibacterial Oxazolidinones Contezolid and Contezolid Acefosamil with Low Serotonergic Neurotoxicity. Chemical Research in Toxicology 34:5, pages 1348-1354.
Crossref
Crossref
Cristina D. Cruz, Pauli Wrigstedt, Karina Moslova, Vladimir Iashin, Heidi Mäkkylä, Léo Ghemtio, Sami Heikkinen, Päivi Tammela & Jesus E. Perea-Buceta. (2021) Installation of an aryl boronic acid function into the external section of -aryl-oxazolidinones: Synthesis and antimicrobial evaluation. European Journal of Medicinal Chemistry 211, pages 113002.
Crossref
Crossref
Ana Victoria Cheng Jaramillo & William M. Wuest. 2021. Antibacterials. Antibacterials.
F Cools, P Delputte & P Cos. (2021)
The search for novel treatment strategies for
Streptococcus pneumoniae
infections
. FEMS Microbiology Reviews.
Crossref
Crossref
Hoang Long Ngo, Dinesh Kumar Mishra, Vivek Mishra & Cong Chien Truong. (2021) Recent advances in the synthesis of heterocycles and pharmaceuticals from the photo/electrochemical fixation of carbon dioxide. Chemical Engineering Science 229, pages 116142.
Crossref
Crossref
Resmin Khatun, Surajit Biswas, Imdadul Haque Biswas, Sk Riyajuddin, Najirul Haque, Kaushik Ghosh & Sk Manirul Islam. (2020) Cu-NPs@COF: A potential heterogeneous catalyst for CO2 fixation to produce 2-oxazolidinones as well as benzimidazoles under moderate reaction conditions. Journal of CO2 Utilization 40, pages 101180.
Crossref
Crossref
Mahmoud H. Teaima, Mohamed K. Elasaly, Samia A. Omar, Mohamed A. El-Nabarawi & Kamel R. Shoueir. (2020) Eco-friendly synthesis of functionalized chitosan-based nanoantibiotic system for potential delivery of linezolid as antimicrobial agents. Saudi Pharmaceutical Journal 28:7, pages 859-868.
Crossref
Crossref
Letícia Souza Lima, Eliana da Costa Alvarenga Brito, Karine Mattos, Eduardo Benedetti Parisotto, Renata Trentin Perdomo & Simone Schneider Weber. (2020) A retrospective cohort study to screen linezolid-induced thrombocytopenia in adult patients hospitalized in the Midwestern Region of Brazil. Hematology, Transfusion and Cell Therapy 42:3, pages 230-237.
Crossref
Crossref
Su-hua Zhang, Zhen-yu Zhu, Zi Chen, Ying Li, Yang Zou, Miao Yan, Yun Xu, Feng Wang, Mou-ze Liu, Min Zhang & Bi-kui Zhang. (2020) Population Pharmacokinetics and Dosage Optimization of Linezolid in Patients with Liver Dysfunction. Antimicrobial Agents and Chemotherapy 64:6.
Crossref
Crossref
De-Yun Cui, Hong-Tao Kong, Yi Yang, Jianfeng Cai, Bo-Yuan Shen, Da-chao Yan, Xiu-Juan Zhang, Ying-Long Qu, Meng-Meng Bai & En Zhang. (2020) Asymmetric synthesis of linezolid thiazolidine-2-thione derivatives via CS2 mediated decarboxylation cyclization. Tetrahedron Letters 61:19, pages 151847.
Crossref
Crossref
Despoina Koulenti, Elena Xu, Andrew Song, Isaac Yin Sum Mok, Drosos E. Karageorgopoulos, Apostolos Armaganidis, Sotirios Tsiodras & Jeffrey Lipman. (2020) Emerging Treatment Options for Infections by Multidrug-Resistant Gram-Positive Microorganisms. Microorganisms 8:2, pages 191.
Crossref
Crossref
Joanna Fedorowicz, Karol Gzella, Paulina Wiśniewska & Jarosław Sączewski. (2019) 2,2′-((1,4-Dimethoxy-1,4-dioxobutane-2,3-diylidene)bis(azanylylidene))bis(quinoline-3-carboxylic acid). Molbank 2019:4, pages M1093.
Crossref
Crossref
Sattar Arshadi, Alireza Banaei, Saeideh Ebrahimiasl, Aazam Monfared & Esmail Vessally. (2019)
Solvent-free incorporation of CO
2
into 2-oxazolidinones: a review
. RSC Advances 9:34, pages 19465-19482.
Crossref
Crossref
Wanqing Zhou, Shuo Gao, Hongjing Xu, Zhifeng Zhang, Fei Chen, Han Shen & Chunni Zhang. (2019) Distribution of the optrA gene in Enterococcus isolates at a tertiary care hospital in China. Journal of Global Antimicrobial Resistance 17, pages 180-186.
Crossref
Crossref
Si-Chan Li, Qi Ye, Hua Xu, Long Zhang & Yang Wang. (2019) Population Pharmacokinetics and Dosing Optimization of Linezolid in Pediatric Patients. Antimicrobial Agents and Chemotherapy 63:4.
Crossref
Crossref
Sadhana Sagar, Shilpa Kaistha, Amar Jyoti Das & Rajesh KumarSadhana Sagar, Shilpa Kaistha, Amar Jyoti Das & Rajesh Kumar. 2019. Antibiotic Resistant Bacteria: A Challenge to Modern Medicine. Antibiotic Resistant Bacteria: A Challenge to Modern Medicine
15
30
.
Pankaj Kumar Singh & Om Silakari. (2018) The Current Status of O-Heterocycles: A Synthetic and Medicinal Overview. ChemMedChem 13:11, pages 1071-1087.
Crossref
Crossref
Laurent Dortet, Philippe Glaser, Najiby Kassis-Chikhani, Delphine Girlich, Philippe Ichai, Marc Boudon, Didier Samuel, Elodie Creton, Dilek Imanci, Rémy Bonnin, Nicolas Fortineau & Thierry Naas. (2018) Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France. Journal of Antimicrobial Chemotherapy 73:1, pages 41-51.
Crossref
Crossref
Omeed Faghih, Zhongsheng Zhang, Ranae M. Ranade, J. Robert Gillespie, Sharon A. Creason, Wenlin Huang, Sayaka Shibata, Ximena Barros-Álvarez, Christophe L. M. J. Verlinde, Wim G. J. Hol, Erkang Fan & Frederick S. Buckner. (2017) Development of Methionyl-tRNA Synthetase Inhibitors as Antibiotics for Gram-Positive Bacterial Infections. Antimicrobial Agents and Chemotherapy 61:11.
Crossref
Crossref
Mahesh S. Vasava, Manoj N. Bhoi, Sanjay K. Rathwa, Mayuri A. Borad, Sneha G. Nair & Hitesh D. Patel. (2017) Drug development against tuberculosis: Past, present and future. Indian Journal of Tuberculosis 64:4, pages 252-275.
Crossref
Crossref
Yasuhiro Tsuji, Nicholas H.G. Holford, Hidefumi Kasai, Chika Ogami, Young‐A Heo, Yoshitsugu Higashi, Akiko Mizoguchi, Hideto To & Yoshihiro Yamamoto. (2017) Population pharmacokinetics and pharmacodynamics of linezolid‐induced thrombocytopenia in hospitalized patients. British Journal of Clinical Pharmacology 83:8, pages 1758-1772.
Crossref
Crossref
Rustam Aminov. (2017) History of antimicrobial drug discovery: Major classes and health impact. Biochemical Pharmacology 133, pages 4-19.
Crossref
Crossref
S. Bhaduri, M.N. Spano & D.P. Arya. 2017. Comprehensive Supramolecular Chemistry II. Comprehensive Supramolecular Chemistry II
71
112
.
M.J. Pucci, C. Callebaut, A. Cathcart & K. Bush. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
511
552
.
Mithila Rajagopal, Melissa J. Martin, Marina Santiago, Wonsik Lee, Veronica N. Kos, Tim Meredith, Michael S. Gilmore & Suzanne Walker. (2016) Multidrug Intrinsic Resistance Factors in Staphylococcus aureus Identified by Profiling Fitness within High-Diversity Transposon Libraries. mBio 7:4.
Crossref
Crossref
A. S. Lyadov, A. A. Kochubeev, E. B. Markova & S. N. Khadzhiev. (2017) Ethylene carbonate production by cyclocondensation of ethylene glycol and urea in the presence of metal oxides and metal acetylacetonates. Petroleum Chemistry 56:9, pages 852-856.
Crossref
Crossref
Amit Kaushik, Abigail M. Heuer, Drew T. Bell, Jeffrey C. Culhane, David C. Ebner, Nicole Parrish, J. Thomas Ippoliti & Gyanu Lamichhane. (2016) An evolved oxazolidinone with selective potency against Mycobacterium tuberculosis and gram positive bacteria. Bioorganic & Medicinal Chemistry Letters 26:15, pages 3572-3576.
Crossref
Crossref
Robert K. Flamm, Rodrigo E. Mendes, Patricia A. Hogan, Jennifer M. Streit, James E. Ross & Ronald N. Jones. (2016) Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014). Antimicrobial Agents and Chemotherapy 60:4, pages 2273-2280.
Crossref
Crossref
Susan Lepri, Federica Buonerba, Laura Goracci, Irene Velilla, Renzo Ruzziconi, Bryan D. Schindler, Susan M. Seo, Glenn W. Kaatz & Gabriele Cruciani. (2016) Indole Based Weapons to Fight Antibiotic Resistance: A Structure–Activity Relationship Study. Journal of Medicinal Chemistry 59:3, pages 867-891.
Crossref
Crossref
Masataka Tajima, Yoshinori Kato, Jun Matsumoto, Iori Hirosawa, Mariko Suzuki, Yuki Takashio, Mao Yamamoto, Yoshifumi Nishi & Harumi Yamada. (2016) Linezolid-Induced Thrombocytopenia Is Caused by Suppression of Platelet Production <i>via</i> Phosphorylation of Myosin Light Chain 2. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 39:11, pages 1846-1851.
Crossref
Crossref
Christina Görgen née Boersch, Kiril Lutsenko, Eugen Merkul, Walter Frank & Thomas J. J. Müller. (2016) Catalytic one-pot synthesis of 4-(hetero)aryl substituted 5-(2-oxoethyl) oxazol-2(3H)-ones by coupling–isomerization–elimination (CIE) sequence. Organic Chemistry Frontiers 3:7, pages 887-896.
Crossref
Crossref
David H. Perlmutter. 2016. Optical Coherence Tomography. Optical Coherence Tomography
81
95
.
Wanqing Zhou, Dongmei Niu, Xiaoli Cao, Mingzhe Ning, Zhifeng Zhang, Han Shen & Kui Zhang. (2015) Clonal dissemination of linezolid-resistant Staphylococcus capitis with G2603T mutation in domain V of the 23S rRNA and the cfr gene at a tertiary care hospital in China. BMC Infectious Diseases 15:1.
Crossref
Crossref
David Sandoval, Andrey V. Samoshin & Javier Read de Alaniz. (2015) Asymmetric Electrophilic α-Amination of Silyl Enol Ether Derivatives via the Nitrosocarbonyl Hetero-ene Reaction. Organic Letters 17:18, pages 4514-4517.
Crossref
Crossref
Jian Meng, Dafang Zhong, Liang Li, Zhengyu Yuan, Hong Yuan, Cen Xie, Jialan Zhou, Chen Li, Mikhail Fedorovich Gordeev, Jinqian Liu & Xiaoyan Chen. (2015) Metabolism of MRX-I, a Novel Antibacterial Oxazolidinone, in Humans: The Oxidative Ring Opening of 2,3-Dihydropyridin-4-One Catalyzed by Non-P450 Enzymes. Drug Metabolism and Disposition 43:5, pages 646-659.
Crossref
Crossref
Michael J. Schlosser, Hiromi Hosako, Ann Radovsky, Mark T. Butt, Dragomir Draganov, Jenifer Vija & Frederick Oleson. (2015) Lack of Neuropathological Changes in Rats Administered Tedizolid Phosphate for Nine Months. Antimicrobial Agents and Chemotherapy 59:1, pages 475-481.
Crossref
Crossref
Shawn Flanagan, Edward E. McKee, Debaditya Das, Paul M. Tulkens, Hiromi Hosako, Jill Fiedler-Kelly, Julie Passarell, Ann Radovsky & Philippe Prokocimer. (2015) Nonclinical and Pharmacokinetic Assessments To Evaluate the Potential of Tedizolid and Linezolid To Affect Mitochondrial Function. Antimicrobial Agents and Chemotherapy 59:1, pages 178-185.
Crossref
Crossref
Arjan W. Kleij. 2015. Green Synthetic Approaches for Biologically Relevant Heterocycles. Green Synthetic Approaches for Biologically Relevant Heterocycles
141
162
.
Giovanna Poce, Martina Cocozza, Sara Consalvi & Mariangela Biava. (2014) SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development. European Journal of Medicinal Chemistry 86, pages 335-351.
Crossref
Crossref
Ryan Tewhey, Bing Gu, Theodoros Kelesidis, Carmen Charlton, April Bobenchik, Janet Hindler, Nicholas J. Schork & Romney M. Humphries. (2014) Mechanisms of Linezolid Resistance among Coagulase-Negative Staphylococci Determined by Whole-Genome Sequencing. mBio 5:3.
Crossref
Crossref
Mikhail F. Gordeev & Zhengyu Y. Yuan. (2014) New Potent Antibacterial Oxazolidinone (MRX-I) with an Improved Class Safety Profile. Journal of Medicinal Chemistry 57:11, pages 4487-4497.
Crossref
Crossref
Thomas A Keating, Troy Lister & Jeroen C Verheijen. (2014) New antibacterial agents: patent applications published in 2011. Pharmaceutical Patent Analyst 3:1, pages 87-112.
Crossref
Crossref
Sharon Pulla, Charlette M. Felton, Punnamchandar Ramidi, Yashraj Gartia, Nawab Ali, Udaya B. Nasini & Anindya Ghosh. (2013) Advancements in oxazolidinone synthesis utilizing carbon dioxide as a C1 source. Journal of CO2 Utilization 2, pages 49-57.
Crossref
Crossref
Yasuhiro Tsuji, Eiji Yukawa, Yoichi Hiraki, Kana Matsumoto, Akiko Mizoguchi, Kunihiko Morita, Hidetoshi Kamimura, Yoshiharu Karube & Hideto To. (2013) Population Pharmacokinetic Analysis of Linezolid in Low Body Weight Patients with Renal Dysfunction. The Journal of Clinical Pharmacology 53:9, pages 967-973.
Crossref
Crossref
Ling-Li Liu, Li-Sheng He, Ying Xu, Zhuang Han, Yong-Xin Li, Jia-Liang Zhong, Xian-Rong Guo, Xi-Xiang Zhang, Kam Ming Ko & Pei-Yuan Qian. (2013) Caspase-3-Dependent Apoptosis of Citreamicin ε-Induced HeLa Cells Is Associated with Reactive Oxygen Species Generation. Chemical Research in Toxicology 26:7, pages 1055-1063.
Crossref
Crossref
Robert K. Flamm, Rodrigo E. Mendes, James E. Ross, Helio S. Sader & Ronald N. Jones. (2013) An international activity and spectrum analysis of linezolid: ZAAPS Program results for 2011. Diagnostic Microbiology and Infectious Disease 76:2, pages 206-213.
Crossref
Crossref
Hooman Hefzi, Bernhard O. Palsson & Nathan E. Lewis. 2013. Handbook of Systems Biology. Handbook of Systems Biology
229
250
.
Robert K. Flamm, David J. Farrell, Rodrigo E. Mendes, James E. Ross, Helio S. Sader & Ronald N. Jones. (2012) LEADER Surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers). Diagnostic Microbiology and Infectious Disease 74:1, pages 54-61.
Crossref
Crossref
Yurika Ikeda-Dantsuji, Taiji Nakae, Koichi Ariyoshi, Hidekazu Mizuno, Hidehiko Moriyama, Osanori Nagura, Akira Suwabe, Kunihiko Fukuchi, Junichi Honda, Mitsuo Kaku, Shigeru Kohno, Hiroshige Mikamo, Yoshihito Niki, Yoshio Takesue, Kazunori Tomono, Katsunori Yanagihara & Hideaki Hanaki. (2012) Limited detectability of linezolid-resistant Staphylococcus aureus by the Etest method and its improvement using enriched media. Journal of Medical Microbiology 61:7, pages 998-1002.
Crossref
Crossref
Azim Ziyaei-Halimehjani, Katayoun Marjani & Akram Ashouri. (2012) A one-pot, three-component synthesis of thiazolidine-2-thiones. Tetrahedron Letters 53:27, pages 3490-3492.
Crossref
Crossref
Junchao Liang, Xudong Tang, Na Guo, Kaiyu Zhang, Aizhen Guo, Xiuping Wu, Xuelin Wang, Zhenhong Guan, Lihui Liu, Fengge Shen, Mingxun Xing, Liqiang Liu, Lei Li & Lu Yu. (2012) Genome-Wide Expression Profiling of the Response to Linezolid in Mycobacterium tuberculosis. Current Microbiology 64:6, pages 530-538.
Crossref
Crossref
Hiroaki Gouda, Yutaka Kobayashi, Takeshi Yamada, Tetsuya Ideguchi, Akihiro Sugawara, Tomoyasu Hirose, Satoshi ?mura, Toshiaki Sunazuka & Shuichi Hirono. (2012) Three-Dimensional Solution Structure of Bottromycin A2: A Potent Antibiotic Active against Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci. CHEMICAL & PHARMACEUTICAL BULLETIN 60:2, pages 169-171.
Crossref
Crossref
Michael R. Barbachyn. 2012. Antibiotic Discovery and Development. Antibiotic Discovery and Development
271
299
.
Karen Joy Shaw & Michael R. Barbachyn. (2011) The oxazolidinones: past, present, and future. Annals of the New York Academy of Sciences 1241:1, pages 48-70.
Crossref
Crossref
Florian M.E. Wagenlehner, Björn Wullt & Gianpaolo Perletti. (2011) Antimicrobials in urogenital infections. International Journal of Antimicrobial Agents 38, pages 3-10.
Crossref
Crossref
Simon Cotton. 2011. Every Molecule Tells a Story. Every Molecule Tells a Story
190
213
.
Rui Liu, Carl Behrens & Chao‐Ying Ni. 2011. Chiral Drugs. Chiral Drugs
253
296
.
David J. Farrell, Rodrigo E. Mendes, James E. Ross, Helio S. Sader & Ronald N. Jones. (2011) LEADER Program Results for 2009: an Activity and Spectrum Analysis of Linezolid Using 6,414 Clinical Isolates from 56 Medical Centers in the United States. Antimicrobial Agents and Chemotherapy 55:8, pages 3684-3690.
Crossref
Crossref
David C. Swinney & Jason Anthony. (2011) How were new medicines discovered?. Nature Reviews Drug Discovery 10:7, pages 507-519.
Crossref
Crossref
Claudia Sala & Ruben C Hartkoorn. (2011) Tuberculosis drugs: new candidates and how to find more. Future Microbiology 6:6, pages 617-633.
Crossref
Crossref
Cristina Seral, Yolanda Sáenz, Sonia Algarate, Estrella Duran, Pilar Luque, Carmen Torres & Francisco Javier Castillo. (2011) Nosocomial outbreak of methicillin- and linezolid-resistant Staphylococcus epidermidis associated with catheter-related infections in intensive care unit patients. International Journal of Medical Microbiology 301:4, pages 354-358.
Crossref
Crossref
Yurika Ikeda-Dantsuji, Hideaki Hanaki, Fuminori Sakai, Chie Yanagisawa, Taiji Nakae, Fuminori Sakai, Kazunori Tomono, Yoshio Takesue, Junichi Honda, Yuriko Nonomiya, Akira Suwabe, Osanori Nagura, Katsunori Yanagihara, Hiroshige Mikamo, Kunihiko Fukuchi, Mitsuo Kaku, Shigeru Kohno, Koichiro Yoshida & Yoshihito Niki. (2011) Linezolid-resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan. Journal of Infection and Chemotherapy 17:1, pages 45-51.
Crossref
Crossref
Yasuhiro Tsuji, Akiko Mizoguchi, Shinichi Sadoh, Yoichi Hiraki, Kana Matsumoto, Kunihiko Morita, Tsutomu Kobayashi, Hidetoshi Kamimura & Yoshiharu Karube. (2011) Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction. Journal of Infection and Chemotherapy 17:1, pages 70-75.
Crossref
Crossref
Florian M. E. Wagenlehner, Wolfgang Weidner & Kurt G. Naber. 2011. Practical Urology: Essential Principles and Practice. Practical Urology: Essential Principles and Practice
91
103
.
Jong Hwa Yum, Sung Hak Choi, Dongeun Yong, Yunsop Chong, Weon Bin Im, Dong-Kwon Rhee & Kyungwon Lee. (2010)
Comparative
In Vitro
Activities of Torezolid (DA-7157) against Clinical Isolates of Aerobic and Anaerobic Bacteria in South Korea
. Antimicrobial Agents and Chemotherapy 54:12, pages 5381-5386.
Crossref
Crossref
Douglas J. Biedenbach, David J. Farrell, Rodrigo E. Mendes, James E. Ross & Ronald N. Jones. (2010) Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program. Diagnostic Microbiology and Infectious Disease 68:4, pages 459-467.
Crossref
Crossref
Yutaka Kobayashi, Maki Ichioka, Tomoyasu Hirose, Kenichiro Nagai, Atsuko Matsumoto, Hidehiro Matsui, Hideaki Hanaki, Rokuro Masuma, Yoko Takahashi, Satoshi Ōmura & Toshiaki Sunazuka. (2010) Bottromycin derivatives: Efficient chemical modifications of the ester moiety and evaluation of anti-MRSA and anti-VRE activities. Bioorganic & Medicinal Chemistry Letters 20:20, pages 6116-6120.
Crossref
Crossref
Xingxian Zhang, Wei Chen, Cheng Li & Xiang Wu. (2009) An efficient and practical synthesis of antibacterial linezolid. Journal of Chemical Research 2009:12, pages 739-740.
Crossref
Crossref
David J. Farrell, Rodrigo E. Mendes, James E. Ross & Ronald N. Jones. (2009) Linezolid surveillance program results for 2008 (LEADER Program for 2008). Diagnostic Microbiology and Infectious Disease 65:4, pages 392-403.
Crossref
Crossref
Vandana Varshney, Nripendra N. Mishra, Praveen K. Shukla & Devi P. Sahu. (2009) Novel 4-N-substituted aryl but-3-ene-1,2-dione derivatives of piperazinyloxazolidinones as antibacterial agents. Bioorganic & Medicinal Chemistry Letters 19:23, pages 6810-6812.
Crossref
Crossref
Takashi Niwa, Akio Suzuki, Seiji Sakakibara, Senji Kasahara, Mitsuru Yasuda, Ayumi Fukao, Katsuhiko Matsuura, Chitoshi Goto, Nobuo Murakami & Yoshinori Itoh. (2009) Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy. Clinical Therapeutics 31:10, pages 2126-2133.
Crossref
Crossref
Adrian Pîrnău, Vasile Chiş, Laszlo Szabo, Onuc Cozar, Mihai Vasilescu, Ovidiu Oniga & Richard A. Varga. (2009) Experimental and theoretical investigation of 5-para-nitro-benzylidene-thiazolidine-2-thione-4-one molecule. Journal of Molecular Structure 924-926, pages 361-370.
Crossref
Crossref
Almudena Rodríguez-Aranda, Maria Daskalaki, Julia Villar, Francisca Sanz, Joaquín R. Otero & Fernando Chaves. (2009) Nosocomial spread of linezolid-resistant Staphylococcus haemolyticus infections in an intensive care unit. Diagnostic Microbiology and Infectious Disease 63:4, pages 398-402.
Crossref
Crossref
Hassan M. Faidallah, E. M. Sharshira & Mohammed S. M. AL-Saadi. (2009) Synthesis And Biological Evaluation Of Some New Alicyclicspiro-2'-(1',3'-Oxazolidine) Derivatives. Heterocyclic Communications 15:1.
Crossref
Crossref
Koichiro Yoshida, Hisashi Shoji, Yoshihito Niki, Hideaki Hanaki, Chie Yanagisawa, Yurika Ikeda-Dantsuji, Kunihiko Fukuchi & Mitsuru Adachi. (2009) Linezolid-resistant methicillin-resistant Staphylococcus aureus isolated after long-term, repeated use of linezolid. Journal of Infection and Chemotherapy 15:6, pages 417-419.
Crossref
Crossref
Dean Shinabarger & George M. Eliopoulos. 2009. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
247
257
.
Reynaldo Dietze, David Jamil Hadad, Bryan McGee, Lucilia Pereira Dutra Molino, Ethel Leonor Noia Maciel, Charles A. Peloquin, Denise F. Johnson, Sara M. Debanne, Kathleen Eisenach, W. Henry Boom, Moises Palaci & John L. Johnson. (2008) Early and Extended Early Bactericidal Activity of Linezolid in Pulmonary Tuberculosis. American Journal of Respiratory and Critical Care Medicine 178:11, pages 1180-1185.
Crossref
Crossref
K. J. Shaw, S. Poppe, R. Schaadt, V. Brown-Driver, J. Finn, C. M. Pillar, D. Shinabarger & G. Zurenko. (2008) In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains. Antimicrobial Agents and Chemotherapy 52:12, pages 4442-4447.
Crossref
Crossref
Adrian Pîrnău, Vasile Chiş, Ovidiu Oniga, Nicolae Leopold, Laszlo Szabo, Maria Baias & Onuc Cozar. (2008) Vibrational and DFT study of 5-(3-pyridyl-methylidene)-thiazolidine-2-thione-4-one. Vibrational Spectroscopy 48:2, pages 289-296.
Crossref
Crossref
Keith Miller, Alexander J. O'Neill, Mark H. Wilcox, Eileen Ingham & Ian Chopra. (2008)
Delayed Development of Linezolid Resistance in
Staphylococcus aureus
following Exposure to Low Levels of Antimicrobial Agents
. Antimicrobial Agents and Chemotherapy 52:6, pages 1940-1944.
Crossref
Crossref
Steven J. Brickner, Michael R. Barbachyn, Douglas K. Hutchinson & Peter R. Manninen. (2008) Linezolid (ZYVOX), the First Member of a Completely New Class of Antibacterial Agents for Treatment of Serious Gram-Positive Infections. Journal of Medicinal Chemistry 51:7, pages 1981-1990.
Crossref
Crossref
Man Chung, Elizabeth Ferreira, Jean Santos, Jeanine Giarolla, Daniela Rando, Adélia Almeida, Priscila Bosquesi, Renato Menegon & Lorena Blau. (2008) Prodrugs for the Treatment of Neglected Diseases. Molecules 13:3, pages 616-677.
Crossref
Crossref
Cesar A. Arias, Martha Vallejo, Jinnethe Reyes, Diana Panesso, Jaime Moreno, Elizabeth Castañeda, Maria V. Villegas, Barbara E. Murray & John P. Quinn. (2008)
Clinical and Microbiological Aspects of Linezolid Resistance Mediated by the
cfr
Gene Encoding a 23S rRNA Methyltransferase
. Journal of Clinical Microbiology 46:3, pages 892-896.
Crossref
Crossref
F.M.E. Wagenlehner, W. Weidner & K.G. Naber. (2008) Antibiotics in Urology – New Essentials. Urologic Clinics of North America 35:1, pages 69-79.
Crossref
Crossref
Vasile Chiş, Adrian Pîrnău, Mihai Vasilescu, Richard A. Varga & Ovidiu Oniga. (2008) X-ray, 1H NMR and DFT study on 5-para-X-benzylidene-thiazolidine derivatives with X=Br, F. Journal of Molecular Structure: THEOCHEM 851:1-3, pages 63-74.
Crossref
Crossref
Yasuhiro Tsuji, Akiko Mizoguchi, Yoichi Hiraki, Waka Hayashi, Ryotaro Kamohara, Hidetoshi Kamimura & Yoshiharu Karube. (2008) Pharmacokinetics of repeated dosing of linezolid in a hemodialysis patient with chronic renal failure. Journal of Infection and Chemotherapy 14:2, pages 156-160.
Crossref
Crossref
JVN Vara Prasad. (2007) New oxazolidinones. Current Opinion in Microbiology 10:5, pages 454-460.
Crossref
Crossref
Adam R. Renslo, Andy Atuegbu, Prudencio Herradura, Priyadarshini Jaishankar, Mingzhe Ji, Karen L. Leach, Michael D. Huband, Michael R. Dermyer, Luping Wu, J.V.N. Vara Prasad & Mikhail F. Gordeev. (2007) A distal methyl substituent attenuates mitochondrial protein synthesis inhibition in oxazolidinone antibacterials. Bioorganic & Medicinal Chemistry Letters 17:18, pages 5036-5040.
Crossref
Crossref
Brijesh Kumar Srivastava, Rina Soni, Jayendra Z. Patel, Manish Solanki, Darshan Valani, Sunil Gupta, Bhupendra Mishra, Vijay Takale, Purvi Pandya, Mukul R. Jain & Pankaj R. Patel. (2007) Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinones. Bioorganic & Medicinal Chemistry Letters 17:18, pages 5227-5232.
Crossref
Crossref
Seok-Ming Toh, Liqun Xiong, Cesar A. Arias, Maria V. Villegas, Karen Lolans, John Quinn & Alexander S. Mankin. (2007)
Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant
Staphylococcus aureus
resistant to the synthetic antibiotic linezolid
. Molecular Microbiology 64:6, pages 1506-1514.
Crossref
Crossref
Elvira Richter, Sabine Rüsch-Gerdes & Doris Hillemann. (2007)
First Linezolid-Resistant Clinical Isolates of
Mycobacterium tuberculosis
. Antimicrobial Agents and Chemotherapy 51:4, pages 1534-1536.
Crossref
Crossref
Yves L. Janin. (2007) Antituberculosis drugs: Ten years of research. Bioorganic & Medicinal Chemistry 15:7, pages 2479-2513.
Crossref
Crossref
Yuko Fujiwara, Akira Matsunaga, Waka Fukuda, Mie Sakamoto, Hideki Matsuo, Toru Imabayashi, Yasuyuki Kakihana & Yuichi Kanmura. (2007) A case of sepsis caused by methicillin-resistant Staphylococcus aureus treated successfully with linezolid in pediatric patient. Journal of the Japanese Society of Intensive Care Medicine 14:4, pages 615-616.
Crossref
Crossref
N. Woodford & M.J. Ellington. (2007) The emergence of antibiotic resistance by mutation. Clinical Microbiology and Infection 13:1, pages 5-18.
Crossref
Crossref
Jianjun Zhang, Hsiao-Nung Chen, Fang-I Chiang, Jon Y. Takemoto, Mekki Bensaci & Cheng-Wei Tom Chang. (2006) Sonication-Assisted Library Synthesis of Oxazolidinone−Carbohydrate Conjugates. Journal of Combinatorial Chemistry 9:1, pages 17-19.
Crossref
Crossref
S.J. Brickner. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
673
698
.
Lucio Vera-Cabrera, Barbara A. Brown-Elliott, Richard J. WallaceJr.Jr., Jorge Ocampo-Candiani, Oliverio Welsh, Sung Hak Choi & Carmen A. Molina-Torres. (2006) In Vitro Activities of the Novel Oxazolidinones DA-7867 and DA-7157 against Rapidly and Slowly Growing Mycobacteria. Antimicrobial Agents and Chemotherapy 50:12, pages 4027-4029.
Crossref
Crossref
Lucio Vera-Cabrera, Eva Gonzalez, Adrian Rendon, Jorge Ocampo-Candiani, Oliverio Welsh, Victor M. Velazquez-Moreno, Sung Hak Choi & Carmen Molina-Torres. (2006)
In Vitro Activities of DA-7157 and DA-7218 against
Mycobacterium tuberculosis
and
Nocardia brasiliensis
. Antimicrobial Agents and Chemotherapy 50:9, pages 3170-3172.
Crossref
Crossref
Lisa Friedman, Jeff D. Alder & Jared A. Silverman. (2006)
Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in
Staphylococcus aureus
. Antimicrobial Agents and Chemotherapy 50:6, pages 2137-2145.
Crossref
Crossref
Adam R. Renslo, Gary W. Luehr & Mikhail F. Gordeev. (2006) Recent developments in the identification of novel oxazolidinone antibacterial agents. Bioorganic & Medicinal Chemistry 14:12, pages 4227-4240.
Crossref
Crossref
Brigitte Berger-Bächi & Nadine McCallum. (2006) State of the knowledge of bacterial resistance. Injury 37:2, pages S20-S25.
Crossref
Crossref
Adam R. Renslo, Hongwu Gao, Priyadarshini Jaishankar, Revathy Venkatachalam, Marcela Gómez, Johanne Blais, Michael Huband, J.V.N. Vara Prasad & Mikhail F. Gordeev. (2006) Conformational constraint in oxazolidinone antibacterials. Part 2: Synthesis and structure–activity studies of oxa-, aza-, and thiabicyclo[3.1.0]hexylphenyl oxazolidinones. Bioorganic & Medicinal Chemistry Letters 16:5, pages 1126-1129.
Crossref
Crossref
Ronald N. Jones, James E. Ross, Thomas R. Fritsche & Helio S. Sader. (2006) Oxazolidinone susceptibility patterns in 2004: report from the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations. Journal of Antimicrobial Chemotherapy 57:2, pages 279-287.
Crossref
Crossref
Jianhua Xu, Ashkan Golshani, Hiroyuki Aoki, Jaanus Remme, John Chosay, Dean L. Shinabarger & M. Clelia Ganoza. (2005) Protected nucleotide G2608 in 23S rRNA confers resistance to oxazolidinones in E. coli. Biochemical and Biophysical Research Communications 328:2, pages 471-476.
Crossref
Crossref
Venkata G. Meka, Howard S. Gold, Amy Cooke, Lata Venkataraman, George M. Eliopoulos, Robert C. MoelleringJrJr & Stephen G. Jenkins. (2004) Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 54:4, pages 818-820.
Crossref
Crossref
F.M.E. Wagenlehner & K.G. Naber. (2004) New drugs for Gram-positive uropathogens. International Journal of Antimicrobial Agents 24, pages 39-43.
Crossref
Crossref
Neha Gandhi, Brijesh K. Srivastava, Vidya B. Lohray & Braj B. Lohray. (2004) Oxazolidine-2-thiones: a molecular modeling study. Tetrahedron Letters 45:33, pages 6269-6272.
Crossref
Crossref
C. Muller-Serieys, H.B. Drugeon, J. Etienne, C. Lascols, R. Leclercq, J. Nguyen & C.J. Soussy. (2004) Activity of linezolid against Gram-positive cocci isolated in French hospitals as determined by three in-vitro susceptibility testing methods. Clinical Microbiology and Infection 10:3, pages 242-246.
Crossref
Crossref
Rob J. Willems, Janetta Top, Derek J. Smith, David I. Roper, Sarah E. North & Neil Woodford. (2003)
Mutations in the DNA Mismatch Repair Proteins MutS and MutL of Oxazolidinone-Resistant or -Susceptible
Enterococcus faecium
. Antimicrobial Agents and Chemotherapy 47:10, pages 3061-3066.
Crossref
Crossref
BARBARA A. JANTAUSCH, JAIME DEVILLE, STUART ADLER, MARIA RAYO MORFIN, PIO LOPEZ, BARBARA EDGE-PADBURY, SHARON NABERHUIS-STEHOUWER & JON B. BRUSS. (2003) Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant Gram-positive bacterial pathogens. Pediatric Infectious Disease Journal 22:9, pages S164-S171.
Crossref
Crossref
SHELDON L. KAPLAN, JAIME G. DEVILLE, RAM YOGEV, MA RAYO MORFIN, ELBA WU, STUART ADLER, BARBARA EDGE-PADBURY, SHARON NABERHUIS-STEHOUWER & JON B. BRUSS. (2003) Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. The Pediatric Infectious Disease Journal 22:8, pages 677-686.
Crossref
Crossref
Jerry R. Colca, William G. McDonald, Daniel J. Waldon, Lisa M. Thomasco, Robert C. Gadwood, Eric T. Lund, Gregory S. Cavey, W. Rodney Mathews, Lonnie D. Adams, Eric T. Cecil, James D. Pearson, Jeffrey H. Bock, John E. Mott, Dean L. Shinabarger, Liqun Xiong & Alexander S. Mankin. (2003) Cross-linking in the Living Cell Locates the Site of Action of Oxazolidinone Antibiotics. Journal of Biological Chemistry 278:24, pages 21972-21979.
Crossref
Crossref
A. Bolmstrom, C.H. Ballow, A. Qwarnstrom, D.J. Biedenbach & R.N. Jones. (2002) Multicentre assessment of linezolid antimicrobial activity and spectrum in Europe: report from the Zyvox® antimicrobial potency study (ZAPS-Europe). Clinical Microbiology and Infection 8:12, pages 791-800.
Crossref
Crossref
P. Sander, L. Belova, Y. G. Kidan, P. Pfister, A. S. Mankin & E. C. Böttger. (2002) Ribosomal and non‐ribosomal resistance to oxazolidinones: species‐specific idiosyncrasy of ribosomal alterations. Molecular Microbiology 46:5, pages 1295-1304.
Crossref
Crossref
I. Chopra, L. Hesse & A.J. O'Neill. (2002) Exploiting current understanding of antibiotic action for discovery of new drugs. Journal of Applied Microbiology 92, pages 4S-15S.
Crossref
Crossref
Charles H. Ballow, Ronald N. Jones & Douglas J. Biedenbach. (2002) A multicenter evaluation of linezolid antimicrobial activity in North America. Diagnostic Microbiology and Infectious Disease 43:1, pages 75-83.
Crossref
Crossref
Hiroyuki Aoki, Lizhu Ke, Susan M. Poppe, Toni J. Poel, Elizabeth A. Weaver, Robert C. Gadwood, Richard C. Thomas, Dean L. Shinabarger & M. Clelia Ganoza. (2002)
Oxazolidinone Antibiotics Target the P Site on
Escherichia
coli
Ribosomes
. Antimicrobial Agents and Chemotherapy 46:4, pages 1080-1085.
Crossref
Crossref
Kazuhiko IRINODA, Syunji NOMURA & Munehiro HASHIMOTO. (2002) Antimicrobial and clinical effect of linezolid (ZYVOX), a new class of synthetic antibacterial drug.. Folia Pharmacologica Japonica 120:4, pages 245-252.
Crossref
Crossref
Chi Sing Lee, Debra A Allwine, Michael R Barbachyn, Kevin C Grega, Lester A Dolak, Charles W Ford, Randy M Jensen, Eric P Seest, Judith C Hamel, Ronda D Schaadt, Douglas Stapert, Betty H Yagi, Gary E Zurenko & Michael J Genin. (2001) Carbon?carbon-linked (pyrazolylphenyl)oxazolidinones with antibacterial activity against multiple drug resistant gram-positive and fastidious gram-negative bacteria. Bioorganic & Medicinal Chemistry 9:12, pages 3243-3253.
Crossref
Crossref
H Onda, F.M.E Wagenlehner, N Lehn & K.G Naber. (2001) In vitro activity of linezolid against Gram-positive uropathogens of hospitalized patients with complicated urinary tract infections. International Journal of Antimicrobial Agents 18:3, pages 263-266.
Crossref
Crossref
Jason Prystowsky, Farida Siddiqui, John Chosay, Dean L. Shinabarger, John Millichap, Lance R. Peterson & Gary A. Noskin. (2001) Resistance to Linezolid: Characterization of Mutations in rRNA and Comparison of Their Occurrences in Vancomycin-Resistant Enterococci. Antimicrobial Agents and Chemotherapy 45:7, pages 2154-2156.
Crossref
Crossref
Ronald N. Jones, Charles H. Ballow & Douglas J. Biedenbach. (2001) Multi-laboratory assessment of the linezolid spectrum of activity using the Kirby-Bauer disk diffusion method: Report of the Zyvox? Antimicrobial Potency Study (ZAPS) in the United States. Diagnostic Microbiology and Infectious Disease 40:1-2, pages 59-66.
Crossref
Crossref
Bernard Gaudilliere, Patrick Bernardelli & Patrick Berna. 2001.
293
318
.
A. R. De Gaudio & C. Adembri. 2001. Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E.. Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E.
781
789
.
Delyth Clemett & Anthony Markham. (2000) Linezolid. Drugs 59:4, pages 815-827.
Crossref
Crossref
Robert C. Gadwood & Dean A. Shinabarger. 2000.
135
144
.